![Grastim Recombinant Human Granulocyte Colony Stimulating Factor Injection, For Clinical, 300 Mcg at Rs 300/unit in Pune Grastim Recombinant Human Granulocyte Colony Stimulating Factor Injection, For Clinical, 300 Mcg at Rs 300/unit in Pune](https://5.imimg.com/data5/SELLER/Default/2022/9/AH/OF/AG/43014790/recombinant-human-granulocyte-colony-stimulating-factor-injection-1000x1000.jpg)
Grastim Recombinant Human Granulocyte Colony Stimulating Factor Injection, For Clinical, 300 Mcg at Rs 300/unit in Pune
![Neutropenia Network on Twitter: "How Is the granulocyte-colony stimulating factor (G-CSF) Dose Adjusted? #Neutropenia https://t.co/hNbjo628Lp" / Twitter Neutropenia Network on Twitter: "How Is the granulocyte-colony stimulating factor (G-CSF) Dose Adjusted? #Neutropenia https://t.co/hNbjo628Lp" / Twitter](https://pbs.twimg.com/media/FDHN0cBXoAYZ2On.jpg)
Neutropenia Network on Twitter: "How Is the granulocyte-colony stimulating factor (G-CSF) Dose Adjusted? #Neutropenia https://t.co/hNbjo628Lp" / Twitter
Differential role of r-met-hu G-CSF on male reproductive function and development in prepubertal domestic mammals | PLOS ONE
G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis - Document - Gale OneFile: Health and Medicine
![Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis | Scientific Reports Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-51982-4/MediaObjects/41598_2019_51982_Fig1_HTML.png)
Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis | Scientific Reports
![White blood cell growth factors (G/GM-CSF) A practice guidelines Prof. Dr. Khaled Abouelkhair, PhD Medical Oncology SCE, Royal College, UK Ass. Professor. - ppt download White blood cell growth factors (G/GM-CSF) A practice guidelines Prof. Dr. Khaled Abouelkhair, PhD Medical Oncology SCE, Royal College, UK Ass. Professor. - ppt download](https://images.slideplayer.com/32/9973077/slides/slide_25.jpg)
White blood cell growth factors (G/GM-CSF) A practice guidelines Prof. Dr. Khaled Abouelkhair, PhD Medical Oncology SCE, Royal College, UK Ass. Professor. - ppt download
![Intermediate-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor Is a Valid Alternative to High-Dose Cyclophosphamide for Mobilizing Peripheral Blood CD34+ Cells in Patients with Multiple Myeloma | Semantic Scholar Intermediate-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor Is a Valid Alternative to High-Dose Cyclophosphamide for Mobilizing Peripheral Blood CD34+ Cells in Patients with Multiple Myeloma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ea70c9980020bfab4ab0d8c74732c2af50d235db/3-Table2-1.png)
Intermediate-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor Is a Valid Alternative to High-Dose Cyclophosphamide for Mobilizing Peripheral Blood CD34+ Cells in Patients with Multiple Myeloma | Semantic Scholar
![Frontiers | Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial Frontiers | Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial](https://www.frontiersin.org/files/Articles/820324/fonc-12-820324-HTML/image_m/fonc-12-820324-g001.jpg)
Frontiers | Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial
![Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy | BMC Cancer | Full Text Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-021-08093-z/MediaObjects/12885_2021_8093_Fig2_HTML.png)
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy | BMC Cancer | Full Text
![Table 2 from Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey | Semantic Scholar Table 2 from Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/278c632b7042bc327e3d3d2ca6440307ee7a11d8/3-Table2-1.png)
Table 2 from Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey | Semantic Scholar
![PDF) The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: PDF) The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization:](https://0.academia-photos.com/attachment_thumbnails/42642917/mini_magick20190217-31973-d3ibz8.png?1550423490)
PDF) The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization:
![Blood Advances on Twitter: "There is a maximum effective G-CSF dose for PBSC mobilization in obese and severely obese donors, above which higher doses add no benefit. #stemcell https://t.co/8eUp3Td1Bb https://t.co/Uk9mzmNcgE" / Twitter Blood Advances on Twitter: "There is a maximum effective G-CSF dose for PBSC mobilization in obese and severely obese donors, above which higher doses add no benefit. #stemcell https://t.co/8eUp3Td1Bb https://t.co/Uk9mzmNcgE" / Twitter](https://pbs.twimg.com/media/ERubYcQWoAoe-z9.jpg)